Neuropharmacology

Journal Title：Neuropharmacology

Neuropharmacology publishes high quality, original research and review articles within the discipline of neuroscience, especially articles with a neuropharmacological component. However, papers within any area of neuroscience will be considered. The journal does not usually accept clinical research, although preclinical neuropharmacological studies in humans may be considered. The journal only considers submissions in which the chemical structures and compositions of experimental agents are readily available in the literature or disclosed by the authors in the submitted manuscript. Only in exceptional circumstances will natural products be considered, and then only if the preparation is well defined by scientific means. Neuropharmacology publishes articles of any length (original research and reviews).

《神经药理学》发表神经科学领域的高质量原创研究和评论文章，尤其是包含神经药理学内容的文章。但是，任何神经科学领域的论文都会被考虑。该期刊通常不接受临床研究，但可能会考虑人类临床前神经药理学研究。该期刊只考虑那些实验药物的化学结构和成分在文献中很容易获得或作者在提交的稿件中披露的投稿。只有在特殊情况下，才会考虑天然产品，而且只有在制备方法通过科学手段明确定义的情况下才会考虑。《神经药理学》发表任何长度的文章（原创研究和评论）。

Neuropharmacology创刊于1970年，由Elsevier Ltd出版商出版，收稿方向涵盖医学 - 神经科学全领域，此刊是该细分领域中属于非常不错的SCI期刊，在行业细分领域中学术影响力较大，专业度认可很高，所以对原创文章要求创新性较高，如果您的文章质量很高，可以尝试。平均审稿速度 约1.0个月 ，影响因子指数4.6，该期刊近期没有被列入国际期刊预警名单，广大学者值得一试。